The CBO analysis focused on the prices of 176 top-selling brand-name drugs and found an average net price of $343 for Medicare Part D. That compared with $118 for Medicaid, $190 for the Department of Veterans Affairs, $184 for the Department of Defense, and $272 for the DoD TRICARE retail pharmacy network.
The report noted that “the much lower net prices in Medicaid are the result of higher manufacturer rebates in that program than in Medicare Part D.” For specialty drugs, the average price ranges from $1,889 in Medicaid to $4,293 in Medicare Part D.
“There is no rational reason why Medicare pays nearly three times more than Medicaid and about twice as much as the VA for the same exact medicine,” Sanders declared.
“Negotiating directly with pharmaceutical companies will substantially reduce the price of prescription drugs, and it is a national embarrassment that the secretary of Health and Human Services is prohibited from doing that on behalf of the more than 40 million Americans who get their prescription drug coverage from Medicare Part D,” he added. “It is time for Congress to take on the greed of the pharmaceutical industry and require Medicare to negotiate lower drug prices.”
Jesus: Hey, Dad? God: Yes, Son? Jesus: Western civilization followed me home. Can I keep it? God: Certainly not! And put it down this minute--you don't know where it's been! Tom Robbins in Another Roadside Attraction